Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 43598-283

This is a description of a medication, DOXOrubicin Hydrochloride Liposome Injection, that comes in a single-dose vial with a dosage of 20 mg/10 mL (2 mg/mL). It is a refrigerated drug that should not be frozen and must be discarded unused. The formulation includes doxorubicin HCI and is meant for intravenous use only. The medication is a liposomal formulation with pegylated liposomes that contain cholesterol, hydrogenated soy phosphatidylcholine (SPC), and W-carbonyl methoxy polyethylene glycol 2000 (DSPE-PEG). Other ingredients are ammonium sulfite, sucrose, histidine, and hydrochloric acid and/or sodium hydroxide. There is no dosage information on the vial, and it is a cytotoxic agent that must be diluted before administration.*

The text describes a medication called DOXOrubicin Hydrochloride Liposome Injection, which is a single-dose vial for intravenous infusion. It is a liposomal formulation that contains PEGTATED posane, and is composed of specific measurements of various ingredients. The package includes dosing instructions and a warning to discard unused portions. The medication should be kept at controlled room temperature and not frozen. The text also contains product codes and the name of the distributor.*

This text appears to be a medical product description for "DOXOrubicin Hydrochloride Liposome Injection" used for intravenous infusion. The product contains 50mg/25 mL (2mg/ml) with instructions for use. The rest of the text includes random characters and cannot be used.*

This appears to be a statistical report for a medical study involving two drugs: Doxorubicin Hydrochloride and Bortezomib. The report includes survival data and graphs for the patients treated with the two drugs, as well as a statistical analysis comparing their efficacy.*